CVKD
Price
$8.40
Change
-$0.27 (-3.11%)
Updated
Jan 14 closing price
Capitalization
19.64M
62 days until earnings call
Intraday BUY SELL Signals
GDTC
Price
$0.94
Change
-$0.28 (-22.95%)
Updated
Jan 14 closing price
Capitalization
11.01M
109 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

CVKD vs GDTC

Header iconCVKD vs GDTC Comparison
Open Charts CVKD vs GDTCBanner chart's image
Cadrenal Therapeutics
Price$8.40
Change-$0.27 (-3.11%)
Volume$46.43K
Capitalization19.64M
CytoMed Therapeutics
Price$0.94
Change-$0.28 (-22.95%)
Volume$147.03K
Capitalization11.01M
CVKD vs GDTC Comparison Chart in %
CVKD
Daily Signal:
Gain/Loss:
GDTC
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
CVKD vs. GDTC commentary
Jan 15, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CVKD is a Hold and GDTC is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jan 15, 2026
Stock price -- (CVKD: $8.40 vs. GDTC: $0.94)
Brand notoriety: CVKD and GDTC are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CVKD: 80% vs. GDTC: 269%
Market capitalization -- CVKD: $19.64M vs. GDTC: $11.01M
CVKD [@Biotechnology] is valued at $19.64M. GDTC’s [@Biotechnology] market capitalization is $11.01M. The market cap for tickers in the [@Biotechnology] industry ranges from $114.05B to $0. The average market capitalization across the [@Biotechnology] industry is $2.24B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CVKD’s FA Score shows that 0 FA rating(s) are green whileGDTC’s FA Score has 0 green FA rating(s).

  • CVKD’s FA Score: 0 green, 5 red.
  • GDTC’s FA Score: 0 green, 5 red.
According to our system of comparison, both CVKD and GDTC are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CVKD’s TA Score shows that 3 TA indicator(s) are bullish while GDTC’s TA Score has 3 bullish TA indicator(s).

  • CVKD’s TA Score: 3 bullish, 5 bearish.
  • GDTC’s TA Score: 3 bullish, 4 bearish.
According to our system of comparison, GDTC is a better buy in the short-term than CVKD.

Price Growth

CVKD (@Biotechnology) experienced а +12.60% price change this week, while GDTC (@Biotechnology) price change was -32.73% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.47%. For the same industry, the average monthly price growth was +3.44%, and the average quarterly price growth was +44.89%.

Reported Earning Dates

CVKD is expected to report earnings on Mar 18, 2026.

GDTC is expected to report earnings on May 04, 2026.

Industries' Descriptions

@Biotechnology (+0.47% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CVKD($19.6M) has a higher market cap than GDTC($11M). CVKD YTD gains are higher at: 23.894 vs. GDTC (-29.955).
CVKDGDTCCVKD / GDTC
Capitalization19.6M11M178%
EBITDA-14.36MN/A-
Gain YTD23.894-29.955-80%
P/E RatioN/AN/A-
Revenue0N/A-
Total Cash3.86MN/A-
Total Debt0N/A-
TECHNICAL ANALYSIS
Technical Analysis
CVKDGDTC
RSI
ODDS (%)
N/A
Bullish Trend 2 days ago
82%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
85%
Momentum
ODDS (%)
Bullish Trend 2 days ago
81%
Bearish Trend 7 days ago
90%
MACD
ODDS (%)
Bullish Trend 2 days ago
79%
Bearish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
86%
Bearish Trend 2 days ago
86%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
87%
Advances
ODDS (%)
Bullish Trend 2 days ago
81%
N/A
Declines
ODDS (%)
Bearish Trend 16 days ago
84%
Bearish Trend 2 days ago
88%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
86%
Aroon
ODDS (%)
Bearish Trend 2 days ago
89%
Bearish Trend 2 days ago
78%
View a ticker or compare two or three
Interact to see
Advertisement
CVKD
Daily Signal:
Gain/Loss:
GDTC
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
BATL1.240.03
+2.48%
Battalion Oil Corp
IEP7.870.04
+0.51%
Icahn Enterprises LP
PLYM21.960.03
+0.14%
Plymouth Industrial REIT
RDCM12.82-0.18
-1.38%
Radcom Ltd
RDDT252.38-6.55
-2.53%
Reddit

CVKD and

Correlation & Price change

A.I.dvisor tells us that CVKD and RADX have been poorly correlated (+29% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that CVKD and RADX's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CVKD
1D Price
Change %
CVKD100%
-3.11%
RADX - CVKD
29%
Poorly correlated
+0.58%
GDTC - CVKD
29%
Poorly correlated
-23.35%
NEVPF - CVKD
27%
Poorly correlated
N/A
ARDX - CVKD
26%
Poorly correlated
-2.13%
BEAM - CVKD
26%
Poorly correlated
+2.49%
More

GDTC and

Correlation & Price change

A.I.dvisor indicates that over the last year, GDTC has been loosely correlated with CYCN. These tickers have moved in lockstep 35% of the time. This A.I.-generated data suggests there is some statistical probability that if GDTC jumps, then CYCN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GDTC
1D Price
Change %
GDTC100%
-23.35%
CYCN - GDTC
35%
Loosely correlated
-0.65%
CVKD - GDTC
29%
Poorly correlated
-3.11%
RPRX - GDTC
29%
Poorly correlated
-0.37%
QSI - GDTC
28%
Poorly correlated
N/A
BDRX - GDTC
27%
Poorly correlated
-8.73%
More